DLL4 and neoplasm: When DLL4 was silenced in vivo using nanoparticle delivery of a DLL4 specific siRNA to mice harboring A2780 or SKOV3ip1 cell line derived xenografts, the targeting of both tumor cells and tumor-associated mouse endothelial cells inhibited tumor growth and deregulated angiogenesis.